The frequency of germline BRCA1 and BRCA2 mutations was tested in Yugoslav breast and breast/ovarian cancer families using combined heteroduplex/single-strand conformation polymorphism analysis for the entire coding region of both genes. Three different recurrent BRCA1 mutations (one 185delAG, one 3447del4 and two 5382insC) were identified in 4 of 12 families (33%), whereas no definite disease-causing alterations of BRCA2 was detected. Genotype analysis revealed a possible common founder effect for each 185delAG and 5382insC. The relatively high frequency of germline BRCA1 mutations determined in this panel of families confirms the important role of BRCA1 in disease predisposition in the Yugoslav population, while the lack of population spe...
The objective of this study was to provide more accurate frequency estimates of breast cancer suscep...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
Objectives: This study was undertaken to determine: 1) Type and prevalence of founder mutations BRCA...
The frequency of germline BRCA1 and BRCA2 mutations was tested in Yugoslav breast and breast/ovarian...
The most significant and well characterized genetic risk factors for breast and/or ovarian cancer ar...
Germline mutations in BRCA1 and BRCA2 account for majority of hereditary breast and ovarian cancer. ...
BRCA1 and BRCA2 genes from 167 candidates (145 families) were scanned for mutations. We identified 1...
Breast cancer is the most frequent malignancy diagnosed in women in the western world, affecting app...
The main focus of this German-wide multi-center study was to establish a BRCA1/2 mutation profile an...
Since the identification of the BRCA1 and BRCA2 genes, several hundred different germline mutations ...
We have undertaken a hospital-based study, to identify possible BRCA1 and BRCA2 founder mutations in...
Sixty high-risk breast and/or ovarian cancer families from North-Eastern Poland were screened for ge...
Incidence of breast cancer ranges from 27 per 100,000 in Middle Africa and Eastern Asia to 92 per 10...
Germ line BRCA1 and/or BRCA2 mutations were screened in 50 Turkish breast and/or ovarian cancer pati...
Family history is a well-recognized risk factor for the development of breast cancer. The isolation ...
The objective of this study was to provide more accurate frequency estimates of breast cancer suscep...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
Objectives: This study was undertaken to determine: 1) Type and prevalence of founder mutations BRCA...
The frequency of germline BRCA1 and BRCA2 mutations was tested in Yugoslav breast and breast/ovarian...
The most significant and well characterized genetic risk factors for breast and/or ovarian cancer ar...
Germline mutations in BRCA1 and BRCA2 account for majority of hereditary breast and ovarian cancer. ...
BRCA1 and BRCA2 genes from 167 candidates (145 families) were scanned for mutations. We identified 1...
Breast cancer is the most frequent malignancy diagnosed in women in the western world, affecting app...
The main focus of this German-wide multi-center study was to establish a BRCA1/2 mutation profile an...
Since the identification of the BRCA1 and BRCA2 genes, several hundred different germline mutations ...
We have undertaken a hospital-based study, to identify possible BRCA1 and BRCA2 founder mutations in...
Sixty high-risk breast and/or ovarian cancer families from North-Eastern Poland were screened for ge...
Incidence of breast cancer ranges from 27 per 100,000 in Middle Africa and Eastern Asia to 92 per 10...
Germ line BRCA1 and/or BRCA2 mutations were screened in 50 Turkish breast and/or ovarian cancer pati...
Family history is a well-recognized risk factor for the development of breast cancer. The isolation ...
The objective of this study was to provide more accurate frequency estimates of breast cancer suscep...
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluatio...
Objectives: This study was undertaken to determine: 1) Type and prevalence of founder mutations BRCA...